Correlation Between YS Biopharma and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both YS Biopharma and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YS Biopharma and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YS Biopharma Co, and Virax Biolabs Group, you can compare the effects of market volatilities on YS Biopharma and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YS Biopharma with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of YS Biopharma and Virax Biolabs.
Diversification Opportunities for YS Biopharma and Virax Biolabs
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between YS Biopharma and Virax is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding YS Biopharma Co, and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and YS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YS Biopharma Co, are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of YS Biopharma i.e., YS Biopharma and Virax Biolabs go up and down completely randomly.
Pair Corralation between YS Biopharma and Virax Biolabs
If you would invest 48.00 in YS Biopharma Co, on August 28, 2024 and sell it today you would earn a total of 0.00 from holding YS Biopharma Co, or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
YS Biopharma Co, vs. Virax Biolabs Group
Performance |
| Timeline |
| YS Biopharma Co, |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Virax Biolabs Group |
YS Biopharma and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with YS Biopharma and Virax Biolabs
The main advantage of trading using opposite YS Biopharma and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YS Biopharma position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| YS Biopharma vs. Revelation Biosciences | YS Biopharma vs. Cardio Diagnostics Holdings | YS Biopharma vs. Biodexa Pharmaceticals | YS Biopharma vs. ZyVersa Therapeutics |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |